Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroblastoma × Immunoglobulin G × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 26 Ovarian Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Fallopian Tube Neoplasms 21 Colorectal Neoplasms 14 Carcinoma, Renal Cell 11 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 10 Glioblastoma 10 Breast Neoplasms 10 Triple Negative Breast Neoplasms 9 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 9 Urinary Bladder Neoplasms 7 Prostatic Neoplasms 7 Brenner Tumor 7 Neoplasm Metastasis 6 Mycosis Fungoides 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Lymphoma, T-Cell, Cutaneous 5 Colonic Neoplasms 5 Sezary Syndrome 4 Sarcoma 4 Rectal Neoplasms 4 Multiple Myeloma 4 Gliosarcoma 4 Endometrial Neoplasms 4 Carcinoma, Transitional Cell 4 Urethral Neoplasms 3

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 Cisplatin 28 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 Granulocyte Colony-Stimulating Factor 26 dinutuximab 25 3-Iodobenzylguanidine 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 humanized 3F8 anti-GD2 monoclonal antibody 14 naxitamab 13 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02914405 2025-10-22

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡